Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$27.21M+2875.96%Company Profile
- CEO
- Michael K. McGarrity
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 252
- Beta
- 0.73
- Country
- BE
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -3.35
Financials
Revenue
$27.21M+2876.0%Net Income
$-11.53MEBITDA
$-1.01MFree Cash Flow
$-5.89MEPS (diluted)
$-0.22Shares Outstanding (diluted)
52.42M+6010.0%Operating Expenses
$21.59MCash & Debt
$19.21MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $107.88M | $-33.52M | $-0.67 |
| 2024 | $90.05M | $-38.07M | $-0.78 |
| 2023 | $70.19M | $-43.10M | $-1.66 |
| 2022 | $37.05M | $-44.04M | $-2.78 |
| 2021 | $22.24M | $-29.00M | $-2.38 |
| 2020 | $18.46M | $-28.66M | $-3.44 |
| 2019 | $11.79M | $-43.10M | $-6.89 |
| 2018 | $28.34M | $-32.45M | $-5.63 |
| 2017 | $40.51M | $-12.29M | $-2.46 |
| 2016 | $29.87M | $-13.17M | $-2.86 |
| 2015 | $17.47M | $-14.47M | $-3.51 |
| 2014 | $11.48M | $-15.26M | $-4.39 |
| 2013 | $7.55M | $-16.18M | $-5.38 |
| 2012 | $4.92M | $-11.87M | $-5.38 |
Valuation
MXDHFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
90-44.90%Social Signal Score
Mentions (3)
- Newsbenzinga.com·52d ago·Positive
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' MDxHealth SA (NASDAQ:MDXH) stock skyrocketed on Friday after the diagnostic company reported mixed quarterly earnings.
View source ↗ - Newsseekingalpha.com·53d ago·Positive
MDxHealth SA (MDXH) Q2 2026 Earnings Call Transcript MDxHealth SA (MDXH) Q2 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·53d ago·Neutral
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates MDxHealth SA (MDXH) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.15 per share a year ago.
View source ↗
Insider trading
Open-market buys and sells by MXDHF officers and directors.
- Bought
- $5.0m
- Sold
- —
2 trades
0 trades
- Mvm Partners, Llcbought
- Mvm Partners, Llcbought
27 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in MXDHF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.